A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism

Clinical trial NCT07706764 · RECRUITING

Trial details

NCT number: NCT07706764
Sponsor: Ascendis Pharma A/S
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypoparathyroidism

Start date: 2026-04-22
Primary completion: 2027-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.